{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:40:14Z","timestamp":1769726414833,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.025","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T19:15:41Z","timestamp":1389122141000},"page":"1100-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Mingbo","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shude","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2013.12.025_bib0005","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/erv.11.60","article-title":"Review of diphtheria, tetanus and pertussis vaccines in clinical development","volume":"10","author":"Kitchin","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"43","key":"10.1016\/j.vaccine.2013.12.025_bib0010","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1016\/j.vaccine.2010.08.023","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper \u2013 recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2013.12.025_bib0015","first-page":"1002","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, January 2008\u2013June 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2013.12.025_bib0020","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.025_bib0025","unstructured":"Organization WH. WHO global action plan to minimize poliovirus facility-associated risk in the post eradication\/post OPV era. Online available at: http:\/\/applicationsemrowhoint\/docs\/who_em_pol_339_e_enpdf."},{"key":"10.1016\/j.vaccine.2013.12.025_bib0030","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.12.025_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"issue":"11","key":"10.1016\/j.vaccine.2013.12.025_bib0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","author":"Murph","year":"1988","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2013.12.025_bib0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1586\/14760584.7.9.1309","article-title":"Kinrix: a new combination DTaP-IPV vaccine for children aged 4\u20136 years","volume":"7","author":"Weston","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2013.12.025_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III clinical studies of diphtheria-tetanus-acellular pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV)","volume":"208","author":"Okada","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.12.025_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.12.025_bib0060","unstructured":"World Health Organization. WHO. Polio laboratory manual. Online available at: http:\/\/wwwwhoint\/vaccines\/en\/poliolab\/WHO-Polio-Manual-9pdf."},{"issue":"13","key":"10.1016\/j.vaccine.2013.12.025_bib0065","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2165\/11209630-000000000-00000","article-title":"Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix\u00ae): a review of its properties and use as a single-dose booster immunization","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.vaccine.2013.12.025_bib0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/11202770-000000000-00000","article-title":"Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10\u201364 years in the US","volume":"23","author":"Plosker","year":"2009","journal-title":"BioDrugs: Clin Immunother Biopharm Gene Ther"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2013.12.025_bib0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0264-410X(00)00299-1","article-title":"Immunogenicity of a hexavalent combination vaccine in rhesus monkeys","volume":"19","author":"Caulfield","year":"2000","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2013.12.025_bib0080","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.12.025_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-1157(86)90028-4","article-title":"Inactivation of poliovirus with beta-propiolactone","volume":"14","author":"Jiang","year":"1986","journal-title":"J Biol Standard"},{"issue":"18","key":"10.1016\/j.vaccine.2013.12.025_bib0090","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2013.12.025_bib0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4161\/hv.6.10.12582","article-title":"Humoral immunity of dTap-IPV vaccine (REPEVAX(R)) administered one month after dT-IPV vaccine (REVAXIS\u00ae) in adults with unknown vaccination history","volume":"6","author":"Larnaudie","year":"2010","journal-title":"Hum Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2013.12.025_bib0100","first-page":"883","article-title":"Global routine vaccination coverage, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.12.025_bib0105","unstructured":"World Health Organization WHO. Global Polio Eradication Initiative Strategic Plan 2010\u20132012. Online available at: www.whoint\/wer\/2012\/wer8712pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T15:52:04Z","timestamp":1538927524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13017568"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}